< Back to latest news & events

Knowledge Hub

No Official Fee to Opt Out of the UPC

February 2016

The Preparatory Committee for the UPC has agreed the Rules on Court fees and recoverable costs for the UPC. The biggest change, and welcome news for proprietors of existing EP patents and applications is that no fee will be payable in order to opt out of the jurisdiction of the UPC. Many have lobbied that this should have always been the case, and will welcome this news.

The Preparatory Committee had made a commitment that the fees for both the opt-out and its withdrawal would be set to reclaim administrative costs only and that the UPC would not profit from either of these. Recognising that the administration burden of opting out rests almost entirely with the applicant and also that any cost to the Court associated with the opt-out is related to processing the fee, the fee has been removed in the final agreed version of the UPC fees here.

Court fees have also now been set, with the maximum ceiling for recoverable costs for proceedings with values of more than €50 million being capped at €2 million. The provisions for seeking reductions have been set at reimbursement, wholly or partially, of and fixed and value-based fee. Interesting the “test” for who can apply for a reimbursement remains the same; it has been speculated that non-practising entities could benefit from this arrangement.

This update was prepared by Martyn Fish, Partner in our Leeds office. If you would like further advice on this or any other matter please contact Martyn or your usual HGF representative or visit our Contact page to get in touch with your nearest HGF office.

Latest updates

Agritech Thymes: Unlocking the Soil Microbiome: Driving Agritech Innovation in the UK

The UK offers an ideal platform for harnessing the untapped potential of soil and plant microorganisms. Although much of my professional experience has focused on the human microbiome, I have …

Read article

The Antibody Series #1 | Quality Characteristics (CQAs) in Antibody Claims: When the Test Method Can Remain Outside the Claim

Introduction Therapeutic antibodies are at the heart of innovations in biotechnology and healthcare. With increasing regulatory requirements and quality expectations, critical quality attributes (CQAs) are becoming essential in the drafting …

Read article
Event - 3rd February 2026

HGF Brand & Design Conference 2026

Join us on 3rd February 2026 for HGF’s Brand & Design Conference, the must attend event for in-house legal teams, brand leaders, creatives, and innovators shaping the future of IP. …

Event details

EU Agrees on NGT Plant Regulation: What It Means for Patents and Licensing

The European Parliament and Council have reached a provisional agreement for plants developed using New Genomic Techniques (NGTs) – below we summarise the main points and set out the requirements …

Read article

When Retail Branding Meets Politics

(Inter IKEA Systems v Algemeen Vlaams Belang (Case C‑298/23) In November 2022, the Flemish political party Vlaams Belang presented its “IKEA-PLAN – Immigratie Kan Echt Anders” (“Immigration Really Can Be Different”). …

Read article

Office Closed Dates December 2025 / January 2026

HGF Office Closed Dates December 2025 / January 2026   UK Thursday 25 and Friday 26 December 2025 CLOSED Thursday 1 January 2026* CLOSED * Friday 2 January 2026 – …

Read article

Often Copied, Never Equaled: When Do Everyday Items Become Subject of Copyright?

The  borderline between ‘pure’ works of art and mere utilitarian objects” –  Can iconic, yet everyday products be protected under copyright? The above question was posed by Advocate General in …

Read article

The end of the Brexit overhang for trade marks: review, refile and revoke.

On the 31st December 2025, five years will have passed since the end of the Brexit transitional period on 31st December 2020. Why is this relevant? For UK cloned trade …

Read article